Richmond Pharmacology
Latest Videos

NIHR CRN video in which patients and network staff talk about their experiences of being involved in clinical research



News

Richmond Pharmacology presents latest Thorough QT studyat the ASCPT 2014 Annual Meeting Moxifloxacin is used as a probe to confirm assay sensitivity in thorough electrocardiogram (ECG)...
Read More
Adaptive Phase I

First Time into Human and beyond

Based within the safe environment of two of the largest NHS teaching hospitals and with the highest clinical research standards certified by the MHRA standard and supplementary accreditation...

...Richmond Pharmacology is ideally suited to run intricate First time into Human studies. Richmond Pharmacology's extensive experience covers a
wide range of therapeutic areas and research methodologies. Full Article »

Bridging Studies

Bridging Studies

Richmond is the leading global provider of Japanese Bridging Studies. Richmond's experienced Japanese team includes doctors, nurses, study managers and recruitment staff who will be involved in all aspects of your study. This team is supported by the entire clinical and operations team...

Richmond has successfully completed in excess of 50 studies in Japanese subjects since 2002, many of which have already been used in regulatory submissions in Japan.

Experience includes First-In-Japanese, Single-Dose, Single-Ascending Dose, Multiple Dose, Multiple-Ascending Dose and combined Single and Multiple Dose protocols. Richmond's unique and successful approach to volunteer advertising and recruitment ensures Richmond are able to recruit a variety of Japanese volunteer populations representative of the Japanese population as required by the Japanese Licensing Authorities. Full Article »

TQT Studies

Thorough QT (TQT) Studies

Richmond Pharmacology is one of the leading providers of TQT studies. All TQT studies performed at Richmond are in collaboration with Professor Camm, Head of Cardiac and Vascular Sciences, Head of Cardiac and Vascular Sciences, St George's University of London...

... A world renowned opinion leader in cardiological analysis, providing a one stop solution unique in the field of contract research. Richmond's innovative approach to the conduct of TQT studies has reduced the variability rates allowing one to reduce the overall costs. In-house expertise and past experience
makes Richmond the ideal partner for performing
definitive TQT studies, all under one roof.

Full Article »

Patient Recruitment

Patient Recruitment

An innovative process driven approach to patient recruitment ensures Richmond can guarantee delivery of a variety of healthy volunteer and patient panels within a budget and time frame that suits your needs...

Numerous techniques introduced by Richmond Pharmacology to deliver a variety of volunteer panels have been adopted by others and have become standard industry practices. However, Richmond's commitment to excel in this area continues to leave competitors trailing behind. Full Article »

Welcome to Richmond Pharmacology

Our reputation has been gained through the successful conduct of over 250 Early Phase Studies since inception in 2001, ranging from testing Anaesthetic agents to Zinamide interaction studies. The specialist areas in which we have really excelled over many years are Adaptive, Thorough-QT, Japanese Bridging Studies and Patient Recruitment – evident in the numerous peer-reviewed papers we have published.

 

 


Welcome to Richmond Pharmacology

Our Business Ethos

Our business ethos is unique:  Our revenues serve the National Health Service and St George’s University of London, fund basic research, support charities or otherwise are reinvested in the business.  Our business is sustainable, adaptive to change and is led by the same specialists who founded the business more than ten years ago.

Our Sponsors

All our sponsors are preferred clients. Richmond Pharmacology’s interaction with its sponsors is personal and truly strategic, generating enhanced value for drug developers and investors.

Our Work

Our work is closely supervised throughout by the same senior specialists sponsors meet during the first consultation or bid defence.  Our services span strategic consultancy and concept development through to final reporting, utilising our many years of experience and leading to successful clinical trials with meaningful results.

 

Read More »

 

Our Specialist Services

Thorough QTc Study Services (TQT Studies)

All our Thorough QT Studies are in collaboration with Professor Camm, Head of Cardiac and Vascular Sciences, St George's University of London, a world renowned opinion leader in cardiological analysis. In-house expertise and experience makes Richmond Pharmacology the ideal partner for performing definitive QTc Study Solutions. Read more about our Thorough Qt Studies

Bridging Studies

We're the leading global provider of Japanese Bridging Studies and have succesfully completed in excess of 50 bridging studies in Japanese subjects since 2002, many of which have already been used in regulatory submissions in Japan.

 

Richmond Pharmacology is Europe's longest established specialist in Japanese bridging studies, our MHRA accredited facilities can accommodate every aspect of a study including, protocol writing and CRF Design, Ethics and Regulatory Approvals, Study Data Management and Statistical Analysis. Our unique approach to volunteer recruitment has ensured that we are able to recruit a variety of Japanese volunteer populations to meet our sponsors' time and cost requirements. Take a look at our Bridging Studies or see Early Phase Bridging Studies to view our latest publications and a case study on RPL’s experience in challenging bridging studies.

First In Man Studies

Uniquely based with 2 prominent NHS London hospitals and certified by the highest level of Regulatory Accreditation, Richmond Pharmacology are First Time Into Human specialists. RPL's extensive experience means they can offer a broad spectrum of first in man study services. Learn More about our First in Man Studies

Patient Recruitment

Our in-house Volunteer and Patient Recruitment department is the largest of any early phase CRO in the UK. We have extensive experience in recruiting a multitude of volunteer panels. Learn more about our Patient Recruitment

Adaptive Study Design

Established as Europe's industry leaders and backed by the support of a highly experienced team of clinical pharmacologists, project managers, a world-class Scientific Advisory Board and a wide range of on-site therapeutically aligned experts, RPL is perfectly equipped for the conduct of complex studies requiring the application of the Adaptive Study Design model in, but not limited to; FTIH, TQT, Japanese and Bridging Studies.

 

Learn more about adaptive design for early phase clinical trials»

Cardiac Safety Studies

As the leading specialist in Cardiac Safety Study Solutions, we know how important the quality of ECG data, speed and regulatory compliance is to our sponsors. It’s no surprise that Richmond Pharmacology’s Cardiac Safety Studies are trusted worldwide.

 

Learn more about our Cardiac Safety Studies »

 

Early Phase Studies

Our reputation has been gained through the successful conduct of over 250 Early Phase Studies since 2001. Our experience spans simple BE studies to complex FTIH studies. Our hospital integrated Phase I unit provides an optimum safety environment for Early Phase Studies »

 

 

MEET THE EXPERTS

Richmond Pharmacology's people have extensive knowledge and expertise.

PUBLICATIONS

 

View our latest
peer-reviewed
publications


View Publications

WE RISE TO THE CHALLENGE

 

We know we can help your
business. We always rise
to the challenge…


Challenge Us
© 2014 Richmond Pharmacology  |  Clinical Research Organization  |  disclaimer  |  Corporate Accounts  |  site map |
clinical trials london